Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin E Offord

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
International Journal of Pharmaceutics|April 19, 2019
Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTESJohn W McBride, R Karl Malcolm, Nicola Dias, et al.
Journal of Virology|May 28, 2003
Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokinesOliver Hartley, Karim Dorgham, Danielle Perez-Bercoff, et al.
Journal of Virology|June 29, 2004
PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypesTatsuyoshi Kawamura, Shannon E Bruse, Awet Abraha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3Yolande Chvatchko, Amanda E I Proudfoot, Raphaële Buser, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
International Journal of Pharmaceutics|April 19, 2019
Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTESJohn W McBride, R Karl Malcolm, Nicola Dias, et al.
Journal of Virology|May 28, 2003
Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokinesOliver Hartley, Karim Dorgham, Danielle Perez-Bercoff, et al.
Journal of Virology|June 29, 2004
PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypesTatsuyoshi Kawamura, Shannon E Bruse, Awet Abraha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3Yolande Chvatchko, Amanda E I Proudfoot, Raphaële Buser, et al.
Pageof 2